Chemical inhibitors of CCDC28A can exert their inhibitory effects through various mechanisms that involve key signaling pathways within the cell. Wortmannin and LY294002, for instance, target the PI3K/Akt pathway, a critical signal transduction route that governs several cellular processes including growth and survival. These inhibitors can prevent the necessary phosphorylation events that CCDC28A relies on for its function, thereby leading to a functional inhibition of the protein. Similarly, staurosporine operates as a broad-spectrum kinase inhibitor and can suppress the activity of kinases that are responsible for phosphorylating CCDC28A, thus preventing its proper functioning.
Other inhibitors like U0126 and PD98059 specifically inhibit MEK, an upstream kinase in the MAPK/ERK pathway. By blocking MEK, these chemicals would hinder the downstream ERK signaling that may regulate CCDC28A's functions. SB203580 and SP600125 focus on the p38 MAP kinase and JNK pathways, respectively. SB203580 impedes the p38 pathway, which is potentially required for CCDC28A's function, while SP600125 obstructs JNK signaling pathways, which can be necessary for CCDC28A's functional activity. Rapamycin is another inhibitor that targets the mTOR pathway, crucial for many cellular processes, and its inhibition could lead to the functional inhibition of CCDC28A. Brefeldin A disrupts protein trafficking by inhibiting the ADP-ribosylation factor (Arf), which might be essential for CCDC28A's role in membrane trafficking, thus functionally inhibiting the protein. The protein kinase C (PKC) inhibitors Go6983 and GF109203X prevent PKC-mediated phosphorylation of CCDC28A, leading to its functional inhibition. Lastly, Genistein, a tyrosine kinase inhibitor, disrupts the tyrosine phosphorylation that may regulate CCDC28A's activity, leading to its functional inhibition. Each of these chemicals targets specific pathways or phosphorylation events that are crucial for CCDC28A's role in the cell, and their inhibition effectively impairs the protein's function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
This chemical inhibits the PI3K/Akt pathway, which is involved in various cellular processes including those that could be governed by CCDC28A. By inhibiting this pathway, wortmannin would reduce the phosphorylation events necessary for CCDC28A's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor similar to wortmannin. It would prevent signal transduction necessary for CCDC28A's activity, thereby functionally inhibiting the protein. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a potent kinase inhibitor, staurosporine can inhibit multiple kinases that could phosphorylate CCDC28A, leading to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
This chemical is an inhibitor of MEK, which is upstream of ERK in the MAPK/ERK pathway. By inhibiting MEK, U0126 would disrupt the ERK signaling that could regulate CCDC28A's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which would impair the activation of the MAPK/ERK pathway and consequently inhibit the function of CCDC28A. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAP kinase inhibitor would disrupt the p38 pathway that may be required for CCDC28A's function, leading to its functional inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
By inhibiting JNK, SP600125 would interfere with the JNK signaling pathways, which could be necessary for the functional activity of CCDC28A. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is crucial for many cellular processes. Inhibition of this pathway could result in the functional inhibition of CCDC28A. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
This chemical disrupts protein trafficking by inhibiting ADP-ribosylation factor (Arf), which could be essential for CCDC28A's role in membrane trafficking, thus functionally inhibiting the protein. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
As a protein kinase C (PKC) inhibitor, Go6983 would prevent the phosphorylation of CCDC28A by PKC, leading to its functional inhibition. | ||||||